Mirae Asset Global Investments’s Corbus Pharmaceuticals CRBP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-24,880	Closed	-$976K	–	1745
2024 Q1	$976K	Buy	+24,880	New	+$614K	﹤0.01%	1552
2022 Q4	–	Sell	-13,298	Closed	-$66K	–	2542
2022 Q3	$66K	Sell	13,298 -121,008	-90%	-$853K	﹤0.01%	2555
2022 Q2	$1.02M	Buy	134,306 +9,141	+7%	+$88.3K	﹤0.01%	1394
2022 Q1	$2M	Sell	125,165 -10,502	-8%	-$139K	﹤0.01%	1155
2021 Q4	$2.51M	Buy	135,667 +2,326	+2%	+$63K	0.01%	1064
2021 Q3	$4.08M	Sell	133,341 -29,645	-18%	-$1.17M	0.01%	911
2021 Q2	$8.95M	Buy	162,986 +49,773	+44%	+$2.76M	0.03%	676
2021 Q1	$6.69M	Buy	113,213 +44,876	+66%	+$2.95M	0.02%	663
2020 Q4	$2.56M	Buy	68,337 +39,017	+133%	+$1.46M	0.01%	841
2020 Q3	$1.58M	Buy	29,320 +4,777	+19%	+$865K	0.01%	838
2020 Q2	$6.18M	Buy	24,543 +2,329	+10%	+$471K	0.04%	449
2020 Q1	$3.49M	Buy	22,214 +336	+2%	+$56.8K	0.03%	511
2019 Q4	$3.58M	Sell	21,878 -15,682	-42%	-$2.32M	0.02%	588
2019 Q3	$5.49M	Buy	37,560 +1,721	+5%	+$300K	0.04%	447
2019 Q2	$7.45M	Buy	+35,839	New	+$7.67M	0.05%	374